Le Lézard
Classified in: Health
Subject: SVY

Worldwide Spectacle Industry to 2026 - Players Include EssilorLuxottica, Novartis and Carl Zeiss Among Others


DUBLIN, March 4, 2021 /PRNewswire/ -- The "Global Spectacle Market By Parts (Lens and Frames), By Distribution Channel (Online and Offline), By Region, Industry Analysis and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The Global Spectacle Market size is expected to reach $102.7 billion by 2026, rising at a market growth of 7% CAGR during the forecast period. Eyewear includes accessories that are used for eyes either to protect them from debris or for vision correction, harmful radiations or extreme light. Eyewear comprises of spectacles, sunglasses, and lenses used for vision correction or to save the eyes from dust particles. Factors like expanding life span, rising geriatric population, and shifting fashion trends have promoted the demand for spectacle across the globe. In the current scenario, eyewear is not only used for vision correction, but also for improving one's appearance. Several market players are providing innovative spectacles and lenses. This is credited to the availability of lightweight materials and technological developments.

An increase in demand for prescribed contact lenses and spectacles due to age-related impairment like presbyopia will boost the global spectacle market. As per the WHO report in 2018, more than 1.3 billion people are already suffering from some or other form of visual impairment in the world, of which around 188.5 million are vulnerable to distance vision, and about 217 million have moderate to severe visual impairment, and approximately 826 million people suffer from near vision impairment. The modern healthcare systems and better life expectancy will increase the geriatric population, thereby impacting the market outlook positively.

Commoditization of the eyewear industry, the impact of entertainment and media personalities, and the inclination towards fashionable spectacles are the factors boosting the product demand. Increasing fashion consciousness among millennials along with the availability of a varied range of trendy spectacles is expected to boost the market. Increasing demand for plastic frames due to their enhanced durability and easy repairing, is expected to push the market growth.

Based on Parts, the market is segmented into Lens and Frames. The frame segment is likely to show the highest CAGR from the year 2020 to 2026. Regular replacement of sight frames is anticipated to boost the growth of the segment. In addition to this, increasing adoption of fiber frames due to their durability is likely to further increase the demand. Furthermore, the introduction of fashionable products united with increasing fashion consciousness among consumers is likely to drive the growth of the segment.

Based on Distribution Channel, the market is segmented into Online and Offline. In 2019, the offline distribution channel garnered the largest market share. Growing demand for handy eyewear is likely to contribute to the growing number of retail stores. Offline stores such as specialty stores and optical shops offer customization, personal assistance, and convenience to the consumers, which in turn will push the segment growth. These stores also provide complete eye check-ups for the consumers to select the correct eyeglasses. Moreover, they offer easy exchange and repair services for lens and frames, which ultimately saves customers money and time.

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. North America acquired the largest market share in 2019. The increasing occurrence of vision impairment that is affected by the augmented use of laptops, computers, smartphones, and other gadgets is expected to boost regional product demand. Factors including a rise in the old age population and occurrence of presbyopia are likely to boost the regional market for spectacles. Asia Pacific is the fastest-growing market of spectacles. Rising inclinations for labelled products along with product accessibility at lesser costs is fuelling the development of business.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include EssilorLuxottica SA (Essilor Instruments USA), Johnson and Johnson (Johnson and Johnson Vision Care, Inc.), Novartis AG (Ciba Vision), Carl Zeiss AG, Zenni Optical, Inc., Jand, Inc. (Warby Parker), Lenskart Solutions Pvt. Ltd., Hoya Corporation, MODO and Titan Group Limited (Tata Group).

Unique Offerings from the Publisher

Key Topics Covered:

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Spectacle Market, by Parts
1.4.2 Global Spectacle Market, by Distribution Channel
1.4.3 Global Spectacle Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global Spectacle Market by Parts
3.1 Global Lens Spectacle Market by Region
3.2 Global Frames Spectacle Market by Region

Chapter 4. Global Spectacle Market by Distribution Channel
4.1 Global Online Market by Region
4.2 Global Offline Market by Region

Chapter 5. Global Spectacle Market by Region
5.1 North America Spectacle Market
5.2 Europe Spectacle Market
5.3 Asia Pacific Spectacle Market
5.4 LAMEA Spectacle Market

Chapter 6. Company Profiles
6.1 EssilorLuxottica SA (Essilor Instruments USA)
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental &Regional Analysis
6.1.4 Research & Development Expenses
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.2 Johnson and Johnson (Johnson and Johnson Vision Care, Inc.)
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental &Regional Analysis
6.2.4 Research & Development Expenses
6.3 Novartis AG (Ciba Vision)
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.4 Carl Zeiss AG
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.5 Zenni Optical, Inc.
6.5.1 Company Overview
6.5.2 Recent strategies and developments:
6.5.2.1 Product Launches and Product Expansions:
6.6 Jand, Inc. (Warby Parker)
6.6.1 Company Overview
6.7 Lenskart Solutions Pvt. Ltd.
6.7.1 Company Overview
6.8 Hoya Corporation
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.8.5 Recent strategies and developments:
6.8.5.1 Partnerships, Collaborations, and Agreements:
6.9 MODO
6.9.1 Company Overview
6.10. Titan Group Limited (Tata Group)
6.10.1 Company Overview
6.10.2 Recent strategies and developments:
6.10.2.1 Geographical Expansions:

For more information about this report visit https://www.researchandmarkets.com/r/gaoonn


Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 07:35
Organicell Regenerative Medicine, Inc. , a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, announced today that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug...

at 07:30
Lowell Farms , a leading, vertically-integrated California cannabis company, will report its financial results for the fiscal First Quarter (ended March 31, 2021) after market closes on May 4. Following the release, Lowell Farms will host an earnings...

at 07:30
HemoShear Therapeutics, Inc., a privately held clinical stage biotechnology company, has identified a second drug target for the treatment of gout under its collaboration with Horizon Therapeutics plc that was established in January 2019. Leveraging...

at 07:30
Sleep Foundation (sleepfoundation.org) has released an article series, COVID-19 and Sleep: an Ongoing Concern, which explores how the COVID-19 pandemic has affected the waking and sleeping hours of the global population. Within the series, Sleep...

at 07:30
MJ Biotech, Inc. , is pleased to report its CBD Extraction partner, Genesis Botanical Research (GBR), has secured another 115 acres of hemp biomass to extract bringing the total amount to 155 acres with the 40 acres previously secured. GBR has...

at 07:25
Oramed Pharmaceuticals Inc. (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced that CEO Nadav Kidron will be featured in a live webinar titled Grand Rounds: a Webinar...



News published on 4 march 2021 at 19:00 and distributed by: